November 1, 2014 *ST (600671.SH) announced that based on confidence in the future development prospects of Tianmu Pharmaceutical and recognition of long-term investment value, Yuanjia Medical, a shareholder holding 12.36% of the company, voluntarily committed: The Company shall not transfer its shares in Tianmu Pharmaceutical within the next 18 months from November 1, 2023 (from November 1, 2023 to April 30, 2025), including the newly added shares due to the conversion of capital reserve into capital stock, distribution of stock dividends, allotment of shares and additional issuance during the commitment period.
*ST目药(600671.SH)：股东源嘉医疗自愿承诺18个月内不减持公司股份
*ST Eye Medicine (600671.SH): Shareholder Yuanjia Medical voluntarily promises not to reduce the company's shares within 18 months
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.